IOSP as reported
Innospec Inc. reported $1.79B of revenue over the trailing twelve months, +0.25% on the year before. 11 reported series are charted on this page, each one as filed.
$1.79B
Revenue, trailing twelve months · to Q1 2026 · +0.25% against the twelve months before
- Net Income
- $114M
Net Income · +323% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $77M
Free Cash Flow · −18% year on year · trailing twelve months to Q1 2026
- Op Margin
- 6.9%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.79B | +0.25% | Q1 2026 |
| Net Income | $114M | +323% | Q1 2026 |
| EPS | $4.59 | +325% | Q1 2026 |
| Gross Margin | 27% | n/a | Q1 2026 |
| Op Margin | 6.9% | n/a | Q1 2026 |
| Net Margin | 6.3% | n/a | Q1 2026 |
| ROE | 4.7% | n/a | Q1 2026 |
| ROA | 3.4% | n/a | Q1 2026 |
| ROIC | −4.4% | n/a | Q1 2021 · 20 quarters behind |
| Free Cash Flow | $77M | −18% | Q1 2026 |
| P/E | 20.8 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Innospec Inc. (IOSP) - Revenue & ProfitRevenue & ProfitInnospec Inc. (IOSP)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Specialty Chemicals
Ranks #35 of 36 by Smart Score